1World Health Organisation. The top 10 causes of death. 2011: Available at : http ://www.who.int/mediacentre/factsheets/fs310/ en/index.html (accessedl2/05,2014). 被引量：1
2Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension : analysis of worldwide data. Lancet,2005,365 : 217-223. 被引量：1
3Pouher N. Global risk of cardiovascular disease. Heart,2003,89: ii2-ii5. 被引量：1
7Vasan RS, Larson MG, Leip EP, et al. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study : a cohort study. Lancet, 2001,358 : 1682-1686. 被引量：1
8Mancia G. Blood pressure reduction and cardiovascular outcomes: past, present, and future. Am J Cardiol, 2007,100 : 3J-9J. 被引量：1
6Fredeisdorf S,Thumann C, Ulucan C, et al. Myocardial hypertrophy and enhanced left ventrieular contractility in Zucker diabetic fatty rats. Cardiovase Patho1,2004,13 ( 1 ) : 11-19. 被引量：1
7Koenig W,Sund M, Ernst E,et al. Association between plasma vis- cosity and blood pressure. Results from the MONICA-projeetAugs- burg. Am J Hypertens, 1991,4(6) :529-536. 被引量：1
9Hajjar I, Kotchen TA. Trends in prevalence, awareness, treat- ment, and control of hypertension in the United States, 1988-2000. .lAMA, 2003,290 ( 2 ) : 199-206. 被引量：1
10Smithwick RH, Thompson JE. Splanchnieectomy for essential hy- pertension; results in 1, 266 cases. J Am Med Assoc, 1953,152 (16) :1501-1504. 被引量：1
